pitavastatin calcium
NDC 68382-483, pitavastatin calcium, tablet, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 68382-483
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206047
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68382-483 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PITAVASTATIN CALCIUM4 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68382-483-16 | 68382048316 | 90 TABLET in 1 BOTTLE (68382-483-16) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c35e747e-10ac-4a76-bce6-187618fc64f9NADAC price for package 68382048316
GET /v1/drugs/nadac/68382048316
Use it
Look up 68382-483 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68382-483 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68382-483. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.